Goldman Sachs’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.74M Buy
480,886
+29,497
+7% +$397K ﹤0.01% 3413
2025
Q4
$5.07M Sell
451,389
-1,894
-0.4% -$21.7K ﹤0.01% 3737
2025
Q3
$5.24M Buy
453,283
+159,274
+54% +$1.87M ﹤0.01% 3606
2025
Q2
$3.6M Sell
294,009
-144
-0% -$1.81K ﹤0.01% 3718
2025
Q1
$4.22M Sell
294,153
-25,466
-8% -$398K ﹤0.01% 3524
2024
Q4
$5.09M Sell
319,619
-98,798
-24% -$1.96M ﹤0.01% 3441
2024
Q3
$10.1M Buy
418,417
+240,463
+135% +$5.5M ﹤0.01% 2721
2024
Q2
$3.54M Buy
177,954
+14,654
+9% +$285K ﹤0.01% 3475
2024
Q1
$3.25M Sell
163,300
-526,337
-76% -$10.2M ﹤0.01% 3477
2023
Q4
$15.5M Sell
689,637
-25,072
-4% -$518K ﹤0.01% 2148
2023
Q3
$14.5M Sell
714,709
-246,233
-26% -$5.58M ﹤0.01% 2069
2023
Q2
$24.6M Sell
960,942
-16,390
-2% -$432K 0.01% 1675
2023
Q1
$29.1M Sell
977,332
-378,365
-28% -$11M 0.01% 1477
2022
Q4
$36.7M Sell
1,355,697
-218,554
-14% -$5.34M 0.01% 1427
2022
Q3
$34.3M Sell
1,574,251
-304,776
-16% -$7.96M 0.01% 1398
2022
Q2
$51.4M Sell
1,879,027
-119,844
-6% -$3.44M 0.01% 1108
2022
Q1
$67M Buy
1,998,871
+392,870
+24% +$12.7M 0.01% 1045
2021
Q4
$55.7M Buy
1,606,001
+170,306
+12% +$5.51M 0.01% 1254
2021
Q3
$44.8M Sell
1,435,695
-22,535
-2% -$765K 0.01% 1357
2021
Q2
$53M Buy
1,458,230
+100,097
+7% +$4.14M 0.01% 1202
2021
Q1
$59.4M Sell
1,358,133
-7,828
-0.6% -$367K 0.02% 1034
2020
Q4
$62.7M Sell
1,365,961
-85,676
-6% -$3.57M 0.02% 947
2020
Q3
$48.2M Sell
1,451,637
-137,024
-9% -$4.38M 0.01% 1031
2020
Q2
$46.7M Buy
1,588,661
+179,633
+13% +$5.2M 0.01% 1011
2020
Q1
$37.9M Sell
1,409,028
-79,194
-5% -$2.36M 0.01% 1059
2019
Q4
$50.2M Sell
1,488,222
-9,098
-0.6% -$329K 0.01% 1142
2019
Q3
$56.1M Buy
1,497,320
+27,648
+2% +$1.05M 0.02% 1035
2019
Q2
$64.1M Sell
1,469,672
-70,389
-5% -$3.01M 0.02% 975
2019
Q1
$65.7M Buy
1,540,061
+5,141
+0.3% +$230K 0.02% 917
2018
Q4
$68.7M Buy
1,534,920
+89,699
+6% +$4.7M 0.02% 849
2018
Q3
$99M Sell
1,445,221
-24,531
-2% -$1.58M 0.03% 770
2018
Q2
$84.1M Sell
1,469,752
-197,532
-12% -$10.4M 0.02% 855
2018
Q1
$76.8M Sell
1,667,284
-42,071
-2% -$2M 0.02% 945
2017
Q4
$78.9M Buy
1,709,355
+91,378
+6% +$4.2M 0.02% 950
2017
Q3
$72.9M Sell
1,617,977
-246,669
-13% -$10.5M 0.02% 1014
2017
Q2
$73.2M Buy
1,864,646
+1,320,735
+243% +$49.9M 0.02% 994
2017
Q1
$20.7M Sell
543,911
-23,290
-4% -$908K 0.01% 1863
2016
Q4
$21M Sell
567,201
-3,410
-0.6% -$122K 0.01% 1929
2016
Q3
$19.8M Buy
570,611
+450,332
+374% +$15.8M 0.01% 1895
2016
Q2
$3.91M Sell
120,279
-50,746
-30% -$1.55M ﹤0.01% 3060
2016
Q1
$4.91M Buy
171,025
+76,274
+80% +$2.03M ﹤0.01% 2733
2015
Q4
$3.17M Sell
94,751
-19,646
-17% -$611K ﹤0.01% 3234
2015
Q3
$3.25M Sell
114,397
-136,743
-54% -$4.77M ﹤0.01% 3293
2015
Q2
$10.2M Sell
251,140
-78,718
-24% -$3.53M ﹤0.01% 2319
2015
Q1
$16.2M Buy
329,858
+32,488
+11% +$1.5M 0.01% 1913
2014
Q4
$13.5M Buy
+297,370
New +$11.7M ﹤0.01% 2111

Other funds holding AVNS